We are live on ! Find out more
AA

ALPS Advisors Portfolio holdings

AUM $21.3B
1-Year Est. Return 21.71%
This Fund
S&P 500
This Quarter Est. Return
-5.35%
1 Year Est. Return
+21.71%
3 Year Est. Return
+77.63%
5 Year Est. Return
+121.1%
10 Year Est. Return
+198.29%
AUM
$14.3B
AUM Growth
-$168M
Cap. Flow
+$80.2M
Cap. Flow %
0.56%
Top 10 Hldgs %
50.75%
Holding
806
New
78
Increased
577
Reduced
108
Closed
39

Top Buys

Rank Stock Value
1
ETP
Energy Transfer Partners, L.P.
ETP
+$659M
2
OKS
Oneok Partners LP
OKS
+$65.6M
3
WES
Western Gas Partners Lp
WES
+$58.2M
4
NS
NuStar Energy L.P.
NS
+$55.6M
5
PAA icon
Plains All American Pipeline
PAA
+$39.2M

Top Sells

Rank Stock Value
1
ETP
Energy Transfer Partners L.p.
ETP
+$1.04B
2
EPD icon
Enterprise Products Partners
EPD
+$54.8M
3
MMP
Magellan Midstream Partners, L.P.
MMP
+$31.8M
4
GG
Goldcorp Inc
GG
+$19.8M
5
VBR icon
Vanguard Small-Cap Value ETF
VBR
+$12.9M

Sector Composition

Rank Sector Weight
1 Energy 59.62%
2 Financials 3.1%
3 Materials 2.91%
4 Healthcare 2.65%
5 Industrials 2.25%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GWPH
176
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
$2.29M 0.02%
22,840
+1,071
+5% +$115K
IRWD icon
177
Ironwood Pharmaceuticals
IRWD
$611M
$2.29M 0.02%
144,486
+9,757
+7% +$142K
AGIO icon
178
Agios Pharmaceuticals
AGIO
$2.16B
$2.24M 0.02%
43,511
+7,176
+20% +$367K
AVB icon
179
AvalonBay Communities
AVB
$27.1B
$2.24M 0.02%
11,636
-90
-0.8% -$17.2K
SA
180
Seabridge Gold
SA
$2.8B
$2.23M 0.02%
206,224
-144,854
-41% -$1.54M
SIOX
181
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
$2.22M 0.02%
11,949
+1,285
+12% +$225K
VTR icon
182
Ventas
VTR
$48.9B
$2.09M 0.01%
30,096
+10
+0% +$666
META icon
183
Meta Platforms (Facebook)
META
$1.51T
$2.09M 0.01%
13,839
+225
+2% +$33.5K
EQR icon
184
Equity Residential
EQR
$25.4B
$2.05M 0.01%
31,076
+40
+0.1% +$2.61K
KYNB
185
Kyntra Bio
KYNB
$28.5M
$2.04M 0.01%
2,525
+352
+16% +$245K
TBPH icon
186
Theravance Biopharma
TBPH
$874M
$1.92M 0.01%
+48,069
New +$1.85M
LOXO
187
DELISTED
Loxo Oncology, Inc
LOXO
$1.89M 0.01%
23,601
+1,623
+7% +$89.9K
SBSW icon
188
Sibanye-Stillwater
SBSW
$5.92B
$1.85M 0.01%
423,587
-101,337
-19% -$672K
NVDA icon
189
NVIDIA
NVDA
$5.01T
$1.79M 0.01%
496,720
+43,440
+10% +$138K
HZNP
190
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$1.74M 0.01%
146,867
+8,136
+6% +$101K
PCRX icon
191
Pacira BioSciences
PCRX
$1.02B
$1.73M 0.01%
36,185
+4,008
+12% +$186K
GILD icon
192
Gilead Sciences
GILD
$161B
$1.68M 0.01%
23,740
+3,481
+17% +$232K
ONCE
193
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
$1.68M 0.01%
28,097
+1,624
+6% +$90.8K
AERI
194
DELISTED
Aerie Pharmaceuticals
AERI
$1.68M 0.01%
31,934
+3,216
+11% +$150K
AMAT icon
195
Applied Materials
AMAT
$426B
$1.65M 0.01%
39,871
+9,040
+29% +$384K
ONC
196
BeOne Medicines Ltd
ONC
$33.8B
$1.62M 0.01%
+36,007
New +$1.42M
HALO icon
197
Halozyme
HALO
$9.72B
$1.62M 0.01%
126,208
+14,807
+13% +$198K
BXP icon
198
Boston Properties
BXP
$11B
$1.6M 0.01%
13,047
– –
MUX icon
199
McEwen Inc
MUX
$1.03B
$1.59M 0.01%
+60,516
New +$1.72M
DBVT
200
DBV Technologies
DBVT
$807M
$1.55M 0.01%
4,351
+204
+5% +$69.7K
6 7
8
9 10

Similar funds

PAG
Private Advisor Group Morristown, New Jersey $21.3B AUM 22.13% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return
IC
IEQ Capital Foster City, California $21.5B AUM 75.26% 1-Year Est. Return
DSA
Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return
VARA
Value Aligned Research Advisors Princeton, New Jersey $20.7B AUM 292.88% 1-Year Est. Return
SC
Savant Capital Rockford, Illinois $20.7B AUM 19.76% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return

ALPS Advisors's Q2 2017 Portfolio in Review

As of Q2 2017, ALPS Advisors held 806 positions worth $14.3B, down 1.2% from $14.5B the previous quarter. Its ten largest holdings account for 51% of the portfolio.

ALPS Advisors's Q2 2017 filing shows 78 new, 577 increased, 108 reduced and 39 closed positions. Its largest new stake was Brookfield: 2,292,089 shares worth $32.1M. The largest sale was Energy Transfer Partners L.p., an estimated $1.04B.

By sector, the portfolio is most concentrated in Energy at 60% of assets, down from 66% a quarter earlier, followed by Financials and Materials.

  • ALPS Advisors's largest Q2 2017 buy was Brookfield: 2,292,089 shares worth $32.1M.
  • ALPS Advisors added most to Energy Transfer Partners, L.P. in Q2 2017, an estimated $659M increase.
  • ALPS Advisors's biggest Q2 2017 reduction was Enterprise Products Partners, cutting an estimated $54.8M.
  • ALPS Advisors fully exited Energy Transfer Partners L.p. in Q2 2017, selling an estimated $1.04B.
  • ALPS Advisors's ten largest holdings make up 51% of its $14.3B portfolio in Q2 2017.
  • ALPS Advisors opened 78 new positions and closed 39 in Q2 2017.
  • ALPS Advisors's portfolio value fell 1.2% quarter-over-quarter to $14.3B.

Based on ALPS Advisors's 13F filing for Q2 2017, filed 3 Aug 2017.